Literature DB >> 17327743

Management of severe acute pancreatitis: it's all about timing.

Marc G H Besselink1, Hjalmar C van Santvoort, Ben J Witteman, Hein G Gooszen.   

Abstract

PURPOSE OF REVIEW: This study provides an update on the treatment of severe acute pancreatitis (SAP) with emphasis on nutrition, infection-prophylaxis, biliary pancreatitis, surgical intervention and new randomized controlled trials. RECENT
FINDINGS: The most relevant new insights are: (i) early enteral nutrition in SAP is not only capable of reducing infectious complications but may also reduce mortality; (ii) there is increasing evidence that antibiotic-prophylaxis is not capable of preventing infectious complications in SAP; (iii) probiotic-prophylaxis is being considered as an alternative with promising experimental results; (iv) in biliary pancreatitis, early endoscopic retrograde cholangiography with sphincterotomy (within 48 h) is beneficial in case of ampullary obstruction, although it may be withheld in the event of negative endoscopic ultrasound; (v) surgical intervention for infected (peri-)pancreatic necrosis is increasingly being postponed; (vi) minimally invasive strategies are being considered as a full alternative for necrosectomy by laparotomy in infected (peri-)pancreatic necrosis; (vii) the Atlanta classification should no longer be used to describe computed tomography findings in acute pancreatitis; and (viii) only five randomized controlled trials of patients with acute pancreatitis are currently registered in the international trial registries.
SUMMARY: Timing of intervention is becoming increasingly important in SAP management.

Entities:  

Mesh:

Year:  2007        PMID: 17327743     DOI: 10.1097/MCC.0b013e328015b8af

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  9 in total

Review 1.  Multidetector CT in emergency radiology: acute and generalized non-traumatic abdominal pain.

Authors:  Pasquale Paolantonio; Marco Rengo; Riccardo Ferrari; Andrea Laghi
Journal:  Br J Radiol       Date:  2016-01-22       Impact factor: 3.039

2.  [Acute pancreatitis].

Authors:  N Teich; S Leinung; S Jonas; J Mössner
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

3.  Changes in antibiotic distribution due to pancreatitis.

Authors:  Kent J Fanning; Thomas A Robertson; Johannes B Prins; Michael S Roberts
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

4.  Characteristics and outcomes of patients undergoing debridement of pancreatic necrosis.

Authors:  Sebron Harrison; Manasi Kakade; Shyam Varadarajula; Justin Parden; Desiree Morgan; John Christein
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

5.  The impact of early goal-directed fluid management on survival in an experimental model of severe acute pancreatitis.

Authors:  Constantin J C Trepte; Kai A Bachmann; Jan H Stork; Till J Friedheim; Andrea Hinsch; Matthias S Goepfert; Olliver Mann; Jakob R Izbicki; Alwin E Goetz; Daniel A Reuter
Journal:  Intensive Care Med       Date:  2013-01-04       Impact factor: 17.440

Review 6.  The role of endoscopic therapy in the minimally invasive management of pancreatic necrosis.

Authors:  Jeffrey James Easler
Journal:  Korean J Intern Med       Date:  2021-01-01       Impact factor: 2.884

7.  Elucidating the Mechanism of Action of Salvia miltiorrhiza for the Treatment of Acute Pancreatitis Based on Network Pharmacology and Molecular Docking Technology.

Authors:  Kunyao Zhu; Man Zhang; Jia Long; Shuqi Zhang; Huali Luo
Journal:  Comput Math Methods Med       Date:  2021-11-24       Impact factor: 2.238

Review 8.  Thoracic epidural analgesia: a new approach for the treatment of acute pancreatitis?

Authors:  Olivier Windisch; Claudia-Paula Heidegger; Raphaël Giraud; Philippe Morel; Léo Bühler
Journal:  Crit Care       Date:  2016-05-04       Impact factor: 9.097

9.  High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial.

Authors:  Katalin Márta; Anikó N Szabó; Dániel Pécsi; Péter Varjú; Judit Bajor; Szilárd Gódi; Patrícia Sarlós; Alexandra Mikó; Kata Szemes; Mária Papp; Tamás Tornai; Áron Vincze; Zsolt Márton; Patrícia A Vincze; Erzsébet Lankó; Andrea Szentesi; Tímea Molnár; Roland Hágendorn; Nándor Faluhelyi; István Battyáni; Dezső Kelemen; Róbert Papp; Attila Miseta; Zsófia Verzár; Markus M Lerch; John P Neoptolemos; Miklós Sahin-Tóth; Ole H Petersen; Péter Hegyi
Journal:  BMJ Open       Date:  2017-09-14       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.